Elanco Animal Health (ELAN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Elanco Animal Health (ELAN) emitió su última guía sobre agosto 5, 2026 para Q3 2026. La compañía estimó unas ganancias por acción en el rango de $0.19 - $0.22, en comparación con una estimación de consenso de EPS de $0.19. Elanco Animal Health también estimó unos ingresos en el rango de $1.2B - $1.22B para el período.
En comparación con la previsión anterior, Elanco Animal Health reducido redujo su previsión de ingresos desde un rango anterior de $5.09B - $5.14B.
Elanco Animal Health ha emitido 34 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 5, 2026. During this period, the company raised its outlook 12 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.27 | $0.34 | $0.11 | $0.13 |
| Actual | $0.34 | $0.40 | $0.13 | $0.19 |
| Surprise | +25.9% | +17.6% | +18.2% | +46.2% |
| Revenue | ||||
| Estimate | $1.31B | $1.28B | $1.09B | $1.09B |
| Actual | $1.37B | $1.37B | $1.14B | $1.14B |
| Surprise | +4.26% | +7.40% | +4.72% | +4.15% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.21 | $0.18 | $0.44 | $0.35 |
| Revenue | ||||
| Consensus | $1.21B | $1.19B | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.34 | $0.27 | 25.9 % |
| Q1 | May 6, 2026 | $0.40 | $0.34 | 17.6 % |
| Q4 | Feb 24, 2026 | $0.13 | $0.11 | 18.2 % |
| Q3 | Nov 5, 2025 | $0.19 | $0.13 | 46.2 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.37B | $1.31B | 4.26 % |
| Q1 | May 6, 2026 | $1.37B | $1.28B | 7.40 % |
| Q4 | Feb 24, 2026 | $1.14B | $1.09B | 4.72 % |
| Q3 | Nov 5, 2025 | $1.14B | $1.09B | 4.15 % |